CD40L, the ligand for CD40 on dendritic cells ( DCs ), plays an important role in their activation and is essential for induction of antigen -specific T -cell responses. In the present study, we investigated the efficacy of antitumor immunity induced by vaccination with DCs engineered to express CD40L and pulsed with Mut1 tumor peptide. Our data show that transfection of DCs with recombinant adenovirus AdV -CD40L resulted in activation of DCs with up -regulated expression of proinflammatory cytokines ( IL -1 and IL -12 ), chemokines ( RANTES, IP -10, and MIP -1 ), and immunologically important cell surface molecules ( CD54, CD80, and CD86 ). Our data also demonstrate that DCs transfected with AdV -CD40L ( DC CD40L ) are able to stimulate enhanced allogeneic T -cell proliferation and Mut1 -specific CD8 + cytotoxic T -cell responses in vitro.